Biomedicines(ISSN 2227-9059) is an open access journal devoted to research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. The aim of Biomedicines is publishing high quality papers that address the challenges in bringing biological agents or novel targeted strategies through identification, development and ultimately to clinical use. It is published quarterly online by MDPI with rapid publication. Biomedicines is covered by ESCI (Web of Science), PubMed and Scope.
https://www.mdpi.com/journal/biomedicines
Section “Natural Compounds in Biomedicine”
https://www.mdpi.com/journal/biomedicines/sections/natural_compounds_biomedicine
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of the biomedical use of natural compounds. Papers aim to review or report the discovery of novel natural compounds, novel medical or health uses of existing natural compounds, bioactivities of natural compounds, pharmaceutical and nutraceutical formulation of natural compounds, new technology for natural compound extraction and purification, pharmacology of natural compounds, combination therapy with natural compounds as supplements, and any new frontiers of natural compound research. Topics include, but are not limited to: in vivo/in vitro bioactivity research, chemical identification and characterization of bioactive natural compounds, clinical study of natural compounds, pharmaceutical formulation of natural compounds (including nano-formulation and prodrug formulation), targeted combination therapies (i.e., synergy between natural compounds and standard chemotherapy), preclinical and clinical pharmacology, synthesis (chemical synthesis and biosynthesis) and modification of natural compounds, and advanced extraction and purification technology to improve yield, purity, and bioactivity.
In collaboration with IWA 2019, the journal /Biomedicines/ sponsors:
The article processing fees for one paper is 550 CHF if submitted before 30 June, 2019, and 1000 CHF after 30 June, 2019.
Contact e-mail: nicole.peng@mdpi.com
Biomedicines Editorial Office
biomedicines@mdpi.com
MDPI AG
St. Alban-Anlage 66
4052 Basel, Switzerland
www.mdpi.com
mdpi.com/journal/biomedicines
